Ligand-Mediated Tumour Suppressive Effect of EGFR in EGFR-Amplified Glioblastoma Through BIN3 Upregulation
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Nature Cell Biology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
EGFR ligand shifts the role of EGFR from oncogene to tumour suppressor in EGFR-amplified glioblastoma by suppressing invasion through BIN3 upregulation
Nat Cell Biol 2022 Aug 01;24(8)1291-1305, G Guo, K Gong, N Beckley, Y Zhang, X Yang, R Chkheidze, KJ Hatanpaa, T Garzon-Muvdi, P Koduru, A Nayab, J Jenks, AA Sathe, Y Liu, C Xing, SY Wu, CM Chiang, B Mukherjee, S Burma, B Wohlfeld, T Patel, B Mickey, K Abdullah, M Youssef, E Pan, DE Gerber, S Tian, JN Sarkaria, SK McBrayer, D Zhao, AA HabibFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.